Association between the p53 polymorphisms and cervical cancer risk: an updated meta-analysis

BackgroundThe association of the p53 rs1042522 and rs17878362 polymorphisms with cervical cancer risk has been reported in several published original studies and meta-analyses. However, the conclusions of these studies were contradictory. Consequently, we conducted an updated meta-analysis to furthe...

Full description

Saved in:
Bibliographic Details
Main Authors: Xi-Qin Zhang, Xiao-Hui Bai, Hui-Zhen Zhang, Xiao-Feng He
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1461737/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849720561335271424
author Xi-Qin Zhang
Xiao-Hui Bai
Hui-Zhen Zhang
Xiao-Feng He
author_facet Xi-Qin Zhang
Xiao-Hui Bai
Hui-Zhen Zhang
Xiao-Feng He
author_sort Xi-Qin Zhang
collection DOAJ
description BackgroundThe association of the p53 rs1042522 and rs17878362 polymorphisms with cervical cancer risk has been reported in several published original studies and meta-analyses. However, the conclusions of these studies were contradictory. Consequently, we conducted an updated meta-analysis to further validate these debates.ObjectiveTo evaluate the association between the p53 rs1042522 and rs17878362 polymorphisms and cervical cancer risk.Materials and MethodsPubMed, Medline, Ovid, Embase, CNKI, and China Wanfang databases were searched. Association was assessed using odds ratio (OR) with 95% confidence interval (CI). Moreover, the false-positive reporting probability (FPRP), Bayesian false-finding probability (BFDP), and Venice criteria were used to assess the credibility of statistically significant association.ResultsA significantly decreased cervical cancer risk was revealed for the p53 rs1042522 polymorphism (Pro/Pro +Arg/Pro vs. Arg/Arg: OR = 0.79, 95% CI = 0.71-0.87; Pro/Pro vs. Arg/Arg: OR = 0.80, 95% CI = 0.70-0.91; Arg/Pro vs. Arg/Arg: OR = 0.78, 95% CI = 0.71-0.86; Pro vs. Arg: OR = 0.87, 95% CI = 0.81-0.93) in overall analysis and several subgroup analyses, such as in Caucasians, Asians, Indians, and so on. However, no significant association was found between the p53 rs17878362 polymorphism and cervical cancer risk. Despite these statistically significant results, reliability analysis using FPRP, BFDP, and Venice criteria deemed all associations “unreliable”.ConclusionsAfter considering the reliability of the results, this study indicates that the p53 rs1042522 polymorphism is not associated with the cervical cancer risk.
format Article
id doaj-art-b8e77acc58604b1a8cc350805b5cf4e0
institution DOAJ
issn 2234-943X
language English
publishDate 2025-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj-art-b8e77acc58604b1a8cc350805b5cf4e02025-08-20T03:11:54ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-02-011510.3389/fonc.2025.14617371461737Association between the p53 polymorphisms and cervical cancer risk: an updated meta-analysisXi-Qin Zhang0Xiao-Hui Bai1Hui-Zhen Zhang2Xiao-Feng He3Department of Gynaecology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, ChinaGuilin Medical University, Guilin, Guangxi, ChinaDepartment of Gynaecology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, ChinaInstitute of Evidence-Based Medicine, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, ChinaBackgroundThe association of the p53 rs1042522 and rs17878362 polymorphisms with cervical cancer risk has been reported in several published original studies and meta-analyses. However, the conclusions of these studies were contradictory. Consequently, we conducted an updated meta-analysis to further validate these debates.ObjectiveTo evaluate the association between the p53 rs1042522 and rs17878362 polymorphisms and cervical cancer risk.Materials and MethodsPubMed, Medline, Ovid, Embase, CNKI, and China Wanfang databases were searched. Association was assessed using odds ratio (OR) with 95% confidence interval (CI). Moreover, the false-positive reporting probability (FPRP), Bayesian false-finding probability (BFDP), and Venice criteria were used to assess the credibility of statistically significant association.ResultsA significantly decreased cervical cancer risk was revealed for the p53 rs1042522 polymorphism (Pro/Pro +Arg/Pro vs. Arg/Arg: OR = 0.79, 95% CI = 0.71-0.87; Pro/Pro vs. Arg/Arg: OR = 0.80, 95% CI = 0.70-0.91; Arg/Pro vs. Arg/Arg: OR = 0.78, 95% CI = 0.71-0.86; Pro vs. Arg: OR = 0.87, 95% CI = 0.81-0.93) in overall analysis and several subgroup analyses, such as in Caucasians, Asians, Indians, and so on. However, no significant association was found between the p53 rs17878362 polymorphism and cervical cancer risk. Despite these statistically significant results, reliability analysis using FPRP, BFDP, and Venice criteria deemed all associations “unreliable”.ConclusionsAfter considering the reliability of the results, this study indicates that the p53 rs1042522 polymorphism is not associated with the cervical cancer risk.https://www.frontiersin.org/articles/10.3389/fonc.2025.1461737/fullp53polymorphismriskcervical cancermeta-analysis
spellingShingle Xi-Qin Zhang
Xiao-Hui Bai
Hui-Zhen Zhang
Xiao-Feng He
Association between the p53 polymorphisms and cervical cancer risk: an updated meta-analysis
Frontiers in Oncology
p53
polymorphism
risk
cervical cancer
meta-analysis
title Association between the p53 polymorphisms and cervical cancer risk: an updated meta-analysis
title_full Association between the p53 polymorphisms and cervical cancer risk: an updated meta-analysis
title_fullStr Association between the p53 polymorphisms and cervical cancer risk: an updated meta-analysis
title_full_unstemmed Association between the p53 polymorphisms and cervical cancer risk: an updated meta-analysis
title_short Association between the p53 polymorphisms and cervical cancer risk: an updated meta-analysis
title_sort association between the p53 polymorphisms and cervical cancer risk an updated meta analysis
topic p53
polymorphism
risk
cervical cancer
meta-analysis
url https://www.frontiersin.org/articles/10.3389/fonc.2025.1461737/full
work_keys_str_mv AT xiqinzhang associationbetweenthep53polymorphismsandcervicalcancerriskanupdatedmetaanalysis
AT xiaohuibai associationbetweenthep53polymorphismsandcervicalcancerriskanupdatedmetaanalysis
AT huizhenzhang associationbetweenthep53polymorphismsandcervicalcancerriskanupdatedmetaanalysis
AT xiaofenghe associationbetweenthep53polymorphismsandcervicalcancerriskanupdatedmetaanalysis